MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-12-0015952
Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories Private Limited - healthcare in Palakol(Mdl), Andhra Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2024
₹60.38 Lakh
▼ 36% YoY
Net profit · FY 2024
₹3.54 Lakh
Net margin 5.9%
EBITDA · FY 2024
₹26.42 Lakh
EBITDA margin 43.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Omics Nextgen Laboratories Private Limited
Data last updated:
Omics Nextgen Laboratories Private Limited is a private limited company based in Palakol(Mdl), Andhra Pradesh, India. It operates in the specialized hospitals segment of the healthcare sector. It was incorporated on 29 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U85110AP2021PTC118398.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Murali Krishna Rao Kommula and Madhu Babu Pulagam.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Palakol(Mdl), Andhra Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.38 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹3.54 Lakh (net margin 5.9%) and EBITDA of ₹26.42 Lakh (EBITDA margin 43.8%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Omics Nextgen Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-12-0015952).
Company Details of Omics Nextgen Laboratories Private Limited
CIN U85110AP2021PTC118398
Registration Number 118398
Incorporation Date 29 May 2021
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AP-12-0015952
Recognitions & Rankings of Omics Nextgen Laboratories
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address11 – 2 – 19/A1, Sri Vijaya Laboratory, Palakol(Mdl), Andhra Pradesh, India – 534260
- IndustryHealthcare, Specialized Hospitals, Human Health Activities
Comprehensive company report
Omics Nextgen Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Omics Nextgen Laboratories Private Limited
The main business activity of Omics Nextgen Laboratories is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Omics Nextgen Laboratories Private Limited FY 2025 filings available
Omics Nextgen Laboratories Private Limited reported revenue of ₹60.38 Lakh (down 36% YoY) for FY 2024.
Revenue · FY 2024
₹60.38 Lakh ▼ 36%
Net profit · FY 2024
₹3.54 Lakh margin 5.9%
EBITDA · FY 2024
₹26.42 Lakh margin 43.8%
Compounded Annual Growth Rate (CAGR) of Omics Nextgen Laboratories Private Limited
Revenue CAGR growth
1 year
▼ 36%
EBITDA CAGR growth
1 year
▲ 316%
Revenue fell 36% in the latest year. EBITDA rose 316% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Omics Nextgen Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹26.42 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.54 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Omics Nextgen Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 43.8% | •••• | •••• |
| Net Profit Margin | 5.9% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Omics Nextgen Laboratories are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Rao Kommula | Director | 29 May 2021 | 5 Years 4 Months | Current |
| Madhu Babu Pulagam Also directs: Drdiagnomics Private Limited | Director | 29 May 2021 | 5 Years 4 Months | Current |
Peer Comparison of Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hardev Lifecare Services Private Limited | ₹60.99 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Ar's Gurugram Gastro & Liver Private Limited | ₹60.64 Lakh (FY 2024) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Dishakritya Foundation | ₹60.6 Lakh (FY 2025) | •••• | •••• | 5749.0% | •••• | Kolkata, West Bengal, India |
| Dr. Nidhi Skin Rehab Solutions Private Limited | ₹60.57 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Kripa Health Care Private Limited | ₹60.49 Lakh (FY 2025) | •••• | •••• | 108.0% | •••• | Patna, Bihar, India |
| Omics Nextgen Laboratories Private Limited this company | ₹60.38 Lakh (FY 2024) | •••• | •••• | -36.0% | •••• | Palakol(Mdl), Andhra Pradesh, India |
| Cudure Healthcare Private Limited | ₹60.28 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Vishakapatanam, Andhra Pradesh, India |
| Pdra Imaging Private Limited | ₹60.26 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Mumbai, Maharashtra, India |
| Zoys Healthcare Services Private Limited | ₹60.13 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Srujan Meditech Private Limited | ₹60.09 Lakh (FY 2025) | •••• | •••• | 273.0% | •••• | Ahmedabad, Gujarat, India |
| Bawa Hospital Private Limited | ₹59.98 Lakh (FY 2024) | •••• | •••• | 32.0% | •••• | Ludhiana, Punjab, India |
Peers are the five companies nearest above and the five nearest below Omics Nextgen Laboratories by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Omics Nextgen Laboratories Private Limited
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Omics Nextgen Laboratories Private Limited
Employment history and EPFO contributions of people linked to Omics Nextgen Laboratories.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Madhu Babu Pulagam was appointed as Director on 29 May 2021.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101163574 was registered on 30 Sep 2025.
AGM
Omics Nextgen Laboratories Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Omics Nextgen Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Appointed
Madhu Babu Pulagam was appointed as Director.
Appointed
Murali Krishna Rao Kommula was appointed as Director.
Incorporation
29 May 2021
Omics Nextgen Laboratories Private Limited was registered on 29 May 2021 with Roc Vijayawada & aged 5 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Omics Nextgen Laboratories Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Omics Nextgen Laboratories Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Omics Nextgen Laboratories Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Omics Nextgen Laboratories Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Omics Nextgen Laboratories Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omics Nextgen Laboratories Private Limited
Omics Nextgen Laboratories is an active private limited company based in Palakol(Mdl), Andhra Pradesh, India. The company works in specialized hospitals, within the healthcare industry. It was incorporated on 29 May 2021 (5+ years old) and is registered under CIN U85110AP2021PTC118398.
Omics Nextgen Laboratories reported revenue of ₹60.38 Lakh for FY 2024 (down 36% YoY).
Omics Nextgen Laboratories has 2 current directors:
- Murali Krishna Rao Kommula - Director
- Madhu Babu Pulagam - Director
Omics Nextgen Laboratories reported a net profit of ₹3.54 Lakh (net margin 5.9%) and EBITDA of ₹26.42 Lakh (EBITDA margin 43.8%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Omics Nextgen Laboratories is U85110AP2021PTC118398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omics Nextgen Laboratories was incorporated on 29 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Omics Nextgen Laboratories by revenue are Hardev Lifecare Services Private Limited, Ar's Gurugram Gastro & Liver Private Limited, Dishakritya Foundation, Dr. Nidhi Skin Rehab Solutions Private Limited, Kripa Health Care Private Limited and 5 more, all in the same principal business activity (Human health activities).
Madhu Babu Pulagam was appointed as Director on 29 May 2021. Murali Krishna Rao Kommula was appointed as Director on 29 May 2021.
Yes, Omics Nextgen Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-12-0015952).
The registered office of Omics Nextgen Laboratories is at 11 – 2 – 19A1, Sri Vijaya Laboratory, PalakolMdl, Andhra Pradesh, India – 534260.
Omics Nextgen Laboratories has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh.